Hereditary Diseases
0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
1 programStudy of Clinical and Molecular Manifestations of Genetic DisordersN/A1 trial
Active Trials
Genome & CompanyKorea - Suwon
1 programStudy of Clinical and Molecular Manifestations of Genetic DisordersN/A
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
GeneDxGenome sequencing
Human BioSciencesStudy of Clinical and Molecular Manifestations of Genetic Disorders
Clinical Trials (2)
Total enrollment: 2,200 patients across 2 trials
UW ISeqU: Clinical Impact of Whole-genome Sequencing in Adults
Start: Jul 2026Est. completion: Jul 20321,000 patients
N/AEnrolling By Invitation
Study of Clinical and Molecular Manifestations of Genetic Disorders
Start: Oct 1994Est. completion: Oct 20001,200 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.